Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant state for a spectrum of lymphoplasmacytic malignancies. The risk of progression of MGUS to a symptomatic therapy requiring plasma cell dyscrasia is about 1% per year. Studies carried out over the previous 10 years have impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Abeykoon, Jithma P, Tawfiq, Reema K, Kumar, Shaji, Ansell, Stephen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty Opinions Ltd 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720897/
https://www.ncbi.nlm.nih.gov/pubmed/36532706
http://dx.doi.org/10.12703/r/11-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720897/
https://www.ncbi.nlm.nih.gov/pubmed/36532706
http://dx.doi.org/10.12703/r/11-34

Ejemplares similares